Back
Biolase 10K Form
Sell
21
BIOLQ
Biolase
Last Price:
$0.0100
Seasonality Move:
28.19%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIOLQ News And Ratings
See the #1 stock for the next 7 days that we like better than BIOLQ
BIOLQ Financial Statistics
Sales & Book Value
| Annual Sales: | $49.2M |
|---|---|
| Cash Flow: | $-4.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.14 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -2.03920 |
|---|---|
| Net Income (TTM): | $-16M |
| Gross Margin: | $16.7M |
| Return on Equity: | -21668.17% |
| Return on Assets: | -48.28% |
Biolase Earnings Forecast
Key Biolase Financial Ratios
-
The Gross Profit Margin over the past 32 years for BIOLQ is 34.02%.
-
The Selling, General & Administrative Expenses for BIOLQ have been equal to 58.29% of Gross Profit Margin.
-
The Research & Development expenses have been 12.21% of Revenue.
-
The Interest Expense is -11.44% of Operating Income.
-
The Net Earning history of BIOLQ is -41.97% of Total Revenues.
-
Per Share Earnings over the last 32 years have been positive in 20 years.
Biolase Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | BIOLQ |
| Website: | biolase.com |
Debt
| Debt-to-Equity Ratio: | -3.37 |
|---|---|
| Current Ratio: | 0.63 |
| Quick Ratio: | 0.23 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |